412 related articles for article (PubMed ID: 22161779)
1. First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.
Salomon CJ
J Pharm Sci; 2012 Mar; 101(3):888-94. PubMed ID: 22161779
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.
Arrúa EC; Seremeta KP; Bedogni GR; Okulik NB; Salomon CJ
Acta Trop; 2019 Oct; 198():105080. PubMed ID: 31299283
[TBL] [Abstract][Full Text] [Related]
4. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
Duschak VG
Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
[TBL] [Abstract][Full Text] [Related]
5. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
Doyle PS; Zhou YM; Engel JC; McKerrow JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
Cencig S; Coltel N; Truyens C; Carlier Y
Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
[TBL] [Abstract][Full Text] [Related]
7. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
8. Current drug therapy and pharmaceutical challenges for Chagas disease.
Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of Chagas' disease: status and new developments.
Cerecetto H; González M
Curr Top Med Chem; 2002 Nov; 2(11):1187-213. PubMed ID: 12171581
[TBL] [Abstract][Full Text] [Related]
10. Antitrypanosomal agents: treatment or threat?
Issa VS; Bocchi EA
Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
[No Abstract] [Full Text] [Related]
11. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnological approaches against Chagas disease.
Romero EL; Morilla MJ
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):576-88. PubMed ID: 19941920
[TBL] [Abstract][Full Text] [Related]
13. [Nifurtimox, a bright future for treatment of Chagas disease].
Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
[TBL] [Abstract][Full Text] [Related]
14. First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up.
Blanchet D; Brenière SF; Schijman AG; Bisio M; Simon S; Véron V; Mayence C; Demar-Pierre M; Djossou F; Aznar C
Infect Genet Evol; 2014 Dec; 28():245-50. PubMed ID: 25448161
[TBL] [Abstract][Full Text] [Related]
15. The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease.
Dias JC; Coura JR; Yasuda MA
Rev Soc Bras Med Trop; 2014; 47(1):123-5. PubMed ID: 24603750
[No Abstract] [Full Text] [Related]
16. [Chagas disease].
Develoux M; Lescure FX; Le Loup G; Pialoux G
Rev Med Interne; 2009 Aug; 30(8):686-95. PubMed ID: 19201068
[TBL] [Abstract][Full Text] [Related]
17. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
Castro JA; de Mecca MM; Bartel LC
Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
19. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
20. New drugs for neglected infectious diseases: Chagas' disease.
Machado FS; Tanowitz HB; Teixeira MM
Br J Pharmacol; 2010 May; 160(2):258-9. PubMed ID: 20423339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
